INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 223 filers reported holding INSMED INC in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,448,573 | +1095.2% | 294,993 | +898.8% | 0.19% | +1068.8% |
| Q2 2023 | $623,210 | +4.0% | 29,536 | -16.0% | 0.02% | 0.0% |
| Q1 2023 | $599,205 | -67.3% | 35,144 | -61.6% | 0.02% | -69.2% |
| Q4 2022 | $1,829,948 | +37.6% | 91,589 | +48.4% | 0.05% | +10.6% |
| Q3 2022 | $1,330,000 | +545.6% | 61,738 | +491.2% | 0.05% | +422.2% |
| Q2 2022 | $206,000 | -21.4% | 10,442 | -6.2% | 0.01% | -25.0% |
| Q1 2022 | $262,000 | -58.6% | 11,136 | -52.1% | 0.01% | -69.2% |
| Q4 2021 | $633,000 | -34.6% | 23,227 | -38.6% | 0.04% | -55.2% |
| Q2 2019 | $968,000 | -28.4% | 37,806 | -18.7% | 0.09% | -9.4% |
| Q1 2019 | $1,352,000 | +865.7% | 46,517 | +339.8% | 0.10% | +336.4% |
| Q4 2016 | $140,000 | -74.5% | 10,576 | -65.1% | 0.02% | -54.2% |
| Q4 2015 | $550,000 | -55.4% | 30,300 | -54.4% | 0.05% | -54.7% |
| Q3 2015 | $1,234,000 | +5.0% | 66,500 | -12.5% | 0.11% | -49.0% |
| Q4 2014 | $1,175,000 | – | 75,987 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $100,415,822 | 8.32% |
| Deep Track Capital, LP | 6,500,000 | $110,825,000 | 4.55% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,932,138 | $49,992,953 | 2.11% |
| Endurant Capital Management LP | 230,006 | $3,921,602 | 2.01% |
| Ikarian Capital, LLC | 485,000 | $8,269,250 | 1.88% |
| MPM BioImpact LLC | 399,192 | $6,806,224 | 1.77% |
| SECTORAL ASSET MANAGEMENT INC | 516,092 | $8,799,369 | 1.69% |
| Novo Holdings A/S | 1,339,304 | $22,835,133 | 1.51% |
| First Light Asset Management, LLC | 750,883 | $12,802,555 | 1.15% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 143,794 | $2,451,688 | 1.01% |